BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15981580)

  • 1. [Comparison of adjuvant activities of glucosaminyl-muramyl dipeptide and of the gene coding for granulocyte-macrophage colony-stimulating factor in DNA immunization against herpes simplex virus].
    Kozlov AIu; Klimova RR; Shingarova LN; Boldyreva EF; Nekrasova OV; Gur'ianova SV; Andronova TM; Novikov VV; Kushch AA
    Mol Biol (Mosk); 2005; 39(3):504-12. PubMed ID: 15981580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes.
    Sin JI; Kim JJ; Ugen KE; Ciccarelli RB; Higgins TJ; Weiner DB
    Eur J Immunol; 1998 Nov; 28(11):3530-40. PubMed ID: 9842896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor.
    Zhai Y; Zhou Y; Li X; Feng G
    Mol Med Rep; 2015 Jul; 12(1):199-209. PubMed ID: 25738258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable effects of the co-administration of a GM-CSF-expressing plasmid on the immune response to flavivirus DNA vaccines in mice.
    Chen H; Gao N; Wu J; Zheng X; Li J; Fan D; An J
    Immunol Lett; 2014 Nov; 162(1 Pt A):140-8. PubMed ID: 25128840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The adjuvant effect of granulocyte macrophage colony stimulating factor (GM-CSF) in dengue virus and hepatitis C virus DNA vaccines].
    Wu JM; Chen H; Sheng ZY; Wang J; Fan DY; Gao N; An J
    Bing Du Xue Bao; 2012 May; 28(3):207-12. PubMed ID: 22764521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex 2. Enhancement of protection by the co-delivery of the GM-CSF gene.
    Fló J; Beatriz Perez A; Tisminetzky S; Baralle F
    Vaccine; 2000 Aug; 18(28):3242-53. PubMed ID: 10869769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.
    Raviprakash K; Marques E; Ewing D; Lu Y; Phillips I; Porter KR; Kochel TJ; August TJ; Hayes CG; Murphy GS
    Virology; 2001 Nov; 290(1):74-82. PubMed ID: 11883007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of retroviral envelope with vaccine-induced CD8
    Bongard N; Lapuente D; Windmann S; Dittmer U; Tenbusch M; Bayer W
    Retrovirology; 2017 Apr; 14(1):28. PubMed ID: 28449719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects.
    Bowne WB; Wolchok JD; Hawkins WG; Srinivasan R; Gregor P; Blachere NE; Moroi Y; Engelhorn ME; Houghton AN; Lewis JJ
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):217-25. PubMed ID: 10850386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular immunization with a plasmid DNA vaccine encoding prM-E protein from Japanese encephalitis virus: enhanced immunogenicity by co-administration of GM-CSF gene and genetic fusions of prM-E protein and GM-CSF.
    Zhai YZ; Li XM; Zhou Y; Ma L; Feng GH
    Intervirology; 2009; 52(3):152-63. PubMed ID: 19521104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine GM-CSF genetic adjuvant facilitates prophylactic DNA vaccine against pseudorabies virus through enhanced immune responses.
    Yoon HA; Aleyas AG; George JA; Park SO; Han YW; Lee JH; Cho JG; Eo SK
    Microbiol Immunol; 2006; 50(2):83-92. PubMed ID: 16490926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of macrophage response in mice after DNA immunization and infection with herpes simplex virus type 1.
    Nagurskaya EV; Zaitseva LG; Kobets NV; Kireeva IV; Bekhalo VA; Kozlov AY; Klimova RR; Gur'yanova SV; Andronova TM; Shingarova LN; Boldyreva EF; Nekrasova OV
    Bull Exp Biol Med; 2005 Dec; 140(6):716-9. PubMed ID: 16848234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with DNA vaccine expressing herpes simplex virus type 1 gD and IL-21 protects against mouse herpes keratitis.
    Hu K; He X; Yu F; Yuan X; Hu W; Liu C; Zhao F; Dou J
    Immunol Invest; 2011; 40(3):265-78. PubMed ID: 21204603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag.
    Qiu JT; Chang TC; Lin CT; Chen YM; Li FQ; Soong YK; Lai CH
    Vaccine; 2007 Jan; 25(2):253-63. PubMed ID: 16971027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic viral therapy with a combination of HF10, a herpes simplex virus type 1 variant and granulocyte-macrophage colony-stimulating factor for murine ovarian cancer.
    Goshima F; Esaki S; Luo C; Kamakura M; Kimura H; Nishiyama Y
    Int J Cancer; 2014 Jun; 134(12):2865-77. PubMed ID: 24265099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection.
    Zheng Q; Fan D; Gao N; Chen H; Wang J; Ming Y; Li J; An J
    Vaccine; 2011 Jan; 29(4):763-71. PubMed ID: 21095256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene.
    Zhang X; Divangahi M; Ngai P; Santosuosso M; Millar J; Zganiacz A; Wang J; Bramson J; Xing Z
    Vaccine; 2007 Jan; 25(7):1342-52. PubMed ID: 17052817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination.
    Sun X; Hodge LM; Jones HP; Tabor L; Simecka JW
    Vaccine; 2002 Jan; 20(9-10):1466-74. PubMed ID: 11818167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of tumor necrosis factor DNA on immune response to DNA immunization against herpes simplex virus].
    Klimova RR; Kozlov AIu; Shingarova LN; Nekrasova OV; Boldyreva EF; Guseva TS; Parshina OV; Malinovskaia VV; Novikov VV; Kushch AA
    Mol Biol (Mosk); 2004; 38(2):333-42. PubMed ID: 15125240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine response to DNA encoding herpes simplex virus type-1 glycoprotein D targeted to the liver.
    Rogers JV; Hull BE; Fink PS; Chiou HC; Bigley NJ
    Vaccine; 2000 Feb; 18(15):1522-30. PubMed ID: 10618550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.